title: [How I treat ... An advanced pancreatic cancer].
abstract: Median survival of advanced pancreatic cancer is about three months. Unfortunately, chemotherapy is not a curative approach. Chemotherapy improves the quality of life and overall survival compared to best supportive care. Nevertheless, as the overall survival remains disappointing, clinical research must ongoing to define better treatment regimen.
authors.affiliation: Service d'Oncologie médicale, CHU, Sart Tilman.
authors.forename: M
authors.initials: M
authors.lastname: Polus
authors.forename: G
authors.initials: G
authors.lastname: Jerusalem
authors.forename: B
authors.initials: B
authors.lastname: Sautois
authors.forename: R M
authors.initials: RM
authors.lastname: Silvestre
authors.forename: G
authors.initials: G
authors.lastname: Fillet
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D011379:Prognosis; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine